NASDAQ:AVTX | Cash Flow Statement | Avalo Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2013-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$36.36M
2026-03-31-$19.63M$17,000.00-$17.69M$25.51M$1.4M
2025-12-31-$13.72M$16,000.00-$14.25M$2.4M$687,000.00
2025-09-30-$30.63M
2025-06-30-$20.77M
2025-03-31-$13.15M$135,000.00-$9.46M$0.00$0.00
2024-12-31-$35.34M$68,000.00-$15.04M$0.00$67.71M
2024-09-30$23.04M
2024-06-30$98.46M
2024-03-31-$121.29M$34,000.00-$6.2M$356,000.00$108.61M
2023-12-31-$8.17M$43,000.00-$2.77M$0.00$1,000.00
2023-09-30-$5.23M
2023-06-30-$8.19M
2023-03-31-$9.96M$33,000.00-$10.05M-$133,000.00$13.75M
2022-12-31-$9.81M$35,000.00-$3.94M$0.00$0.00$82,000.00
2022-09-30$3.19M
2022-06-30-$12.99M
2022-03-31-$22.05M$67,000.00-$16.07M$0.00$0.00$0.00
2021-12-31-$19.2M$295,000.00-$17.1M$11,000.00-$11,000.00$76,000.00
2021-09-30-$17.4M
2021-06-30-$17.11M
2021-03-31-$30.68M$451,000.00-$18.32M$21,000.00-$21,000.00$37.83M
2020-12-31-$15.64M$538,000.00-$14.38M$0.00-$391,000.00$200,000.00
2020-09-30-$13.46M
2020-06-30-$13.28M
2020-03-31-$21.12M$453,000.00-$5.74M$0.00-$1.25M$9.1M
2019-12-31$1.62M$617,254.00-$1.68M$2.00-$180,991.00$135,502.00
2019-09-30-$4.02M
2019-06-30-$6.22M
2019-03-31-$7.45M$1.1M-$3.12M$165,969.00-$165,969.00$8.82M
2018-12-31-$5.56M$1.22M-$1.98M$499,358.00-$499,357.00$6.17M
2018-09-30-$24.6M
2018-06-30-$6.01M
2018-03-31-$3.88M$1.02M-$280,423.00$19,224.00-$19,225.00$363,390.00
2017-12-31-$3.09M$408,426.00-$2.55M$15,335.00-$18.9M$11,430.00
2017-09-30$18.72M
2017-06-30-$1.8M
2017-03-31-$1.96M$5,830.00-$2.24M$1,801.00-$1,801.00$120,959.00
2016-12-31-$1.64M-$3.71M$9,237.00
2016-09-30-$6.17M
2016-06-30-$3.52M
2016-03-31-$5.14M-$3.71M$8,898.00
2015-12-31-$3.65M-$3.55M$0.00
2015-09-30-$691,081.00
2015-06-30-$2.91M
2015-03-31-$3.24M-$3.07M
2014-12-31-$2.52M-$3.97M$0.00
2014-09-30-$5.84M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$78.26M$344,000.00-$51.46M-$81.72M$14.59M
2024-12-31-$35.13M$169,000.00-$49.06M$356,000.00$175.85M
2023-12-31-$31.54M$158,000.00-$30.68M-$133,000.00$25.04M
2022-12-31-$41.66M$166,000.00-$26.75M$95,000.00-$95,000.00-$14.7M
2021-12-31-$84.38M$1.66M-$70.89M$113,000.00-$113,000.00$106.76M
2020-12-31-$63.5M$1.84M-$40.54M$63,000.00$11.13M$44.78M
2019-12-31-$16.07M$3.88M-$19.13M$262,013.00-$443,002.00$12.56M
2018-12-31-$40.05M$4.55M-$3.13M$564,415.00$865,461.00$10.4M
2017-12-31$11.87M$425,476.00$12.58M$23,325.00-$18.91M$3.74M
2016-12-31-$16.47M$26,856.00-$14.57M$34,883.00-$34,883.00-$1.43M
2015-12-31-$10.49M$23,508.00-$10.16M$19,984.00-$19,984.00$19.6M
2014-12-31-$16.06M-$15.52M$19,502.00
2013-12-31-$13.05M-$11.49M$29,268.00